Announcements Trials
Browse Landscape

Status

Recruiting 17Active not recruiting 9Suspended 2Withdrawn 1Terminated 1Enrolling by invitation 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Gastrointestinal 12Breast 9Genitourinary 7Thoracic 5CNS 4Sarcoma 3Plasma cell 3Other hematologic neoplasm 3Lymphoid 3Dermatologic 3Myeloid 2Tumor-Agnostic 1Other solid neoplasm 1Head & Neck 1Gynecologic 1Classical hematology 1

Conditions

Neoplasms 1

Interventions

Gemcitabine 13pembrolizumab 12Capecitabine 9Irinotecan 8Erlotinib Hydrochloride 8Carboplatin 8Blood Specimen Collection 8Nivolumab 7Docetaxel 7Cisplatin 7Cetuximab 7Paclitaxel 6Everolimus 6130-nm albumin-bound paclitaxel 6vadimezan 5Magnetic Resonance Spectroscopy 5Fluorouracil 5Cyclophosphamide 5trametinib 4Leucovorin 4Lapatinib 4Ipilimumab 4Bevacizumab 4Albumin-Bound Paclitaxel 4temsirolimus 3atezolizumab 3abemaciclib 3Trastuzumab 3Radiotherapy 3Radiation 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Terminated × Specimen Handling × Tumor-Agnostic × Clear all
NCT05746169 2025-12-30

Discovering Cancer Risks From Environmental Contaminants and Maternal/Child Health

University of California, San Francisco

Terminated
1,576 enrolled
Tumor-Agnostic

Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡